AORT
Artivion Inc

321
Mkt Cap
$2.12B
Volume
24,185.00
52W High
$48.25
52W Low
$21.97
PE Ratio
-179.30
AORT Fundamentals
Price
$43.12
Prev Close
$43.39
Open
$43.27
50D MA
$45.38
Beta
0.99
Avg. Volume
360,150.41
EPS (Annual)
-$0.32
P/B
4.69
Rev/Employee
$242,835.63
Loading...
Loading...
News
all
press releases
Relative Strength Alert For Artivion
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·6d ago
News Placeholder
More News
News Placeholder
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks linger.
Zacks·15d ago
News Placeholder
RBOT Enters Strategic Software Partnership to Streamline Development
Vicarious Surgical inks a software execution partnership to streamline development, cut costs and improve predictability.
Zacks·21d ago
News Placeholder
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
Here is how Idexx Laboratories (IDXX) and Artivion (AORT) have performed compared to their sector so far this year.
Zacks·22d ago
News Placeholder
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
Edwards Lifesciences wins FDA approval for SAPIEN M3, the first transseptal TMVR, expanding minimally invasive options for high-risk mitral regurgitation patients.
Zacks·25d ago
News Placeholder
Squarepoint Ops LLC Takes $664,000 Position in Artivion, Inc. $AORT
Squarepoint Ops LLC bought a new position in Artivion, Inc. (NYSE:AORT - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought...
MarketBeat·27d ago
News Placeholder
Wall Street Zen Upgrades Artivion (NYSE:AORT) to Strong-Buy
Wall Street Zen raised Artivion from a "buy" rating to a "strong-buy" rating in a research note on Sunday...
MarketBeat·1mo ago
News Placeholder
Artivion (NYSE:AORT) Hits New 1-Year High - Still a Buy?
Artivion (NYSE:AORT) Hits New 1-Year High - What's Next...
MarketBeat·1mo ago
News Placeholder
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases
Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.
Zacks·1mo ago
News Placeholder
Artivion (NYSE:AORT) Cut to "Buy" at Wall Street Zen
Wall Street Zen downgraded Artivion from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·1mo ago
<
1
2
...
>

Latest AORT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.